Medigen Vaccine Biologics Corporation (TPEX: 6547)

Medigen Vaccine Biologics Revenue

Medigen Vaccine Biologics had revenue of 243.01M TWD in the quarter ending September 30, 2024, with 11.33% growth. This brings the company's revenue in the last twelve months to 648.17M, up 167.82% year-over-year. In the year 2023, Medigen Vaccine Biologics had annual revenue of 389.62M with 6.73% growth.

• Revenue (ttm): 648.17M
• Revenue Growth: +167.82%
• P/S Ratio: 24.87
• Revenue / Employee: 6.29M
• Employees: 103
• Market Cap: 16.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%
Dec 31, 2020	11.51M	10.39M	927.41%
Dec 31, 2019	1.12M	-	-